Canada Approved Vaccine to Prevent HPV-Related Oropharyngeal and Head and Neck Cancers
Quebec-based Merck Canada today announced Health Canada approved an expanded indication of GARDASIL®9 in individuals 9 through 45 years of age to prevent infection caused by the Human Papillomavirus … more